Phase 3 Study to Evaluate the Lot Consistency of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine
Clinical trial NCT05040789 · WITHDRAWN
Trial details
- NCT number
- NCT05040789
- Sponsor
- Medicago
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-22
- Primary completion
- 2022-05-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.